ML驱动的阿尔茨海默病预测:一个深层集体建模方法
Mustafa Lateef Fadhil Jumaili1, Emrullah Sonuç2
1Department of Computer Engineering, Karabuk University, Karabük, 78050, Türkiye; Department of Computer Science, College of Computer Science and Mathematics, Tikrit University, Tikrit, 34001, Iraq.
SLAS technology
|May 19, 2025
概括
这项研究介绍了用于阿尔茨海默病 (AD) 诊断的集合学习模型. 该模型使用MRI扫描实现了99.32%的准确性,为早期检测提供了强大的工具.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经系统疾病,导致认知能力下降.
- 早期和准确的AD检测对于管理和治疗至关重要.
- 深度学习对分析医疗图像进行诊断非常有希望.
研究的目的:
- 开发一个集体学习框架,以改善阿尔茨海默病的诊断.
- 将多个深度学习架构结合起来,以提高诊断准确度.
- 为了验证模型在不同数据集上的性能,以验证其临床适用性.
主要方法:
- 一个整体学习框架,整合了VGG16,VGG19,ResNet50,InceptionV3和EfficientNetB7.7的学习框架.
- 在来自伊拉克的3714张MRI脑部扫描数据集上进行培训和测试 (非痴呆症,轻度痴呆症,极度痴呆症).
- 在外部数据集上的验证:OASIS和ADNI.
主要成果:
- 拟议的投票组合模型在主要数据集上实现了99.32%的诊断准确性.
- 外部验证显示了高性能:86.6%的OASIS和99.5%的ADNI.
- 该模型在所有痴呆症阶段都表现出高精度和回忆.
结论:
- 合体学习有效地提高了使用MRI扫描的阿尔茨海默病诊断的准确性.
- 开发的模型是早期AD检测的可靠和强大的工具.
- 这些发现表明在神经退行性疾病诊断中临床应用的巨大潜力.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.4K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.2K
相关概念视频
01:26Alzheimer's Disease: Overview
409
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
409
01:22Alzheimer's Disease: Treatment
141
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
141
01:30Dementia
82
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
82